Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.1.1 Global Driver for Pharmaceutical Demand 11
1.1.2 R&D Pipeline in Pharmaceutical Industry 11
1.1.3 Top Pharma Drugs by Sales (In $Million) 12
1.2 Industry Trends 12
2 Report Outline 14
2.1 Report Scope 14
2.2 Report Summary 14
2.3 Research Methodology 15
2.4 Report Assumptions 15
3 Market Snapshot 17
3.1 Market Definition - Infoholic Research 17
3.2 Causes of Osteoporosis 17
3.3 Risk Factors for Osteoporosis 17
3.4 Symptoms of Osteoporosis 18
3.5 Segmented Addressable Market (SAM) 18
3.6 Trends of the Osteoporosis Drugs Market 18
3.7 Related Markets 20
3.7.1 Thrombosis Drugs 20
3.7.2 Immunotherapy Drugs 21
3.7.3 Oncology Drugs 22
4 Market Outlook 24
4.1 Market Segmentation 24
4.2 PEST Analysis 25
4.3 Porter 5 (Five) Forces 26
5 Market Characteristics 27
5.1 DRO -Market Dynamics 27
5.1.1 Drivers 27
5.1.1.1 Increasing geriatric population and upsurge in the incidence of osteoporosis 27
5.1.1.2 Growing awareness about osteoporotic care 28
5.1.2 Opportunities 28
5.1.2.1 Rise in healthcare expenditure in developing countries 28
5.1.2.2 Increased approval of new drugs and pipeline products 28
5.1.3 Restraints 29
5.1.3.1 Expiration of patents and emergence of generics 29
5.1.3.2 Side-effects associated with osteoporosis drugs 29
5.2 DRO - Impact Analysis 30
5.3 Key Stakeholders 31
6 Drug Class: Market Size and Analysis 32
6.1 Overview 32
6.2 Bisphosphonates 33
6.3 Parathyroid Hormone Therapy (PTH) 34
6.4 Selective Estrogen Receptor Modulator (SERM) 35
6.5 Rank Ligand Inhibitors 35
6.6 Biosimilars 36
6.7 Others 37
7 Regions: Market Size and Analysis 39
7.1 Overview 39
7.2 North America 40
7.3 Europe 41
7.4 APAC 42
7.4.1 Overview 42
7.5 Rest of the World 43
8 Competitive Landscape 45
8.1 Overview 45
9 Vendors Profile 47
9.1 Amgen, Inc. 47
9.2 Novartis AG 49
9.3 Eli Lilly & Company Ltd. 52
9.4 Pfizer Inc. 55
9.5 Radius Health, Inc. 58
10 Companies to Watch For 61
10.1 Teva Pharmaceutical Industries Ltd. 61
10.2 F. Hoffmann-La Roche Ltd. 62
10.3 GlaxoSmithKline plc 64
10.4 Novo Nordisk A/S 65
10.5 Merck & Co. 67
Annexure 70
Abbreviations 70
?
